B-Multi-tissue_structure	0	13	Neurovascular	Neurovascular	JJ	B-NP
O	14	21	effects	effect	NNS	I-NP
O	22	24	of	of	IN	B-PP
O	25	29	CD47	CD47	NN	B-NP
O	30	39	signaling	signaling	NN	I-NP
O	39	40	:	:	:	O
O	41	50	promotion	promotion	NN	B-NP
O	51	53	of	of	IN	B-PP
B-Cell	54	58	cell	cell	NN	B-NP
O	59	64	death	death	NN	I-NP
O	64	65	,	,	,	O
O	66	78	inflammation	inflammation	NN	B-NP
O	78	79	,	,	,	O
O	80	83	and	and	CC	O
O	84	95	suppression	suppression	NN	B-NP
O	96	98	of	of	IN	B-PP
O	99	111	angiogenesis	angiogenesis	NN	B-NP
O	112	114	in	in	IN	B-PP
B-Cell	115	120	brain	brain	NN	B-NP
I-Cell	121	132	endothelial	endothelial	JJ	I-NP
I-Cell	133	138	cells	cell	NNS	I-NP
O	139	141	in	in	FW	B-ADVP
O	142	147	vitro	vitro	FW	I-ADVP
O	147	148	.	.	.	O

O	149	152	The	The	DT	B-NP
O	153	160	concept	concept	NN	I-NP
O	161	163	of	of	IN	B-PP
O	164	167	the	the	DT	B-NP
B-Multi-tissue_structure	168	181	neurovascular	neurovascular	JJ	I-NP
O	182	186	unit	unit	NN	I-NP
O	187	197	emphasizes	emphasize	VBZ	B-VP
O	198	202	that	that	IN	B-SBAR
O	203	209	common	common	JJ	B-NP
O	210	217	signals	signal	NNS	I-NP
O	218	221	and	and	CC	I-NP
O	222	232	substrates	substrate	NNS	I-NP
O	233	241	underlie	underlie	VBP	B-VP
O	242	245	the	the	DT	B-NP
O	246	256	physiology	physiology	NN	I-NP
O	257	260	and	and	CC	I-NP
O	261	276	pathophysiology	pathophysiology	NN	I-NP
O	277	279	of	of	IN	B-PP
B-Multi-tissue_structure	280	288	neuronal	neuronal	JJ	B-NP
O	289	292	and	and	CC	I-NP
B-Multi-tissue_structure	293	304	endothelial	endothelial	JJ	I-NP
I-Multi-tissue_structure	305	317	compartments	compartment	NNS	I-NP
O	318	320	in	in	IN	B-PP
B-Organ	321	326	brain	brain	NN	B-NP
O	326	327	.	.	.	O

O	328	334	Recent	Recent	JJ	B-NP
O	335	339	data	datum	NNS	I-NP
O	340	347	suggest	suggest	VBP	B-VP
O	348	352	that	that	IN	B-SBAR
O	353	363	activation	activation	NN	B-NP
O	364	366	of	of	IN	B-PP
O	367	370	the	the	DT	B-NP
O	371	379	integrin	integrin	NN	I-NP
O	379	380	-	-	HYPH	B-VP
O	380	390	associated	associate	VBN	B-NP
O	391	398	protein	protein	NN	I-NP
O	399	403	CD47	CD47	NN	I-NP
O	404	412	promotes	promote	VBZ	B-VP
B-Cell	413	421	neuronal	neuronal	JJ	B-NP
I-Cell	422	426	cell	cell	NN	I-NP
O	427	432	death	death	NN	I-NP
O	432	433	.	.	.	O

O	434	436	Is	Be	VBZ	O
O	437	439	it	it	PRP	B-NP
O	440	448	possible	possible	JJ	B-ADJP
O	449	453	that	that	IN	B-SBAR
O	454	458	CD47	CD47	NN	B-NP
O	459	462	may	may	MD	B-VP
O	463	467	also	also	RB	I-VP
O	468	478	negatively	negatively	RB	I-VP
O	479	485	affect	affect	VB	I-VP
B-Cell	486	494	cerebral	cerebral	JJ	B-NP
I-Cell	495	506	endothelial	endothelial	JJ	I-NP
I-Cell	507	512	cells	cell	NNS	I-NP
O	512	513	?	?	.	O

O	514	522	Exposure	Exposure	NN	B-NP
O	523	525	of	of	IN	B-PP
O	526	530	wild	wild	JJ	B-NP
O	530	531	-	-	HYPH	I-NP
O	531	535	type	type	NN	I-NP
O	536	543	primary	primary	JJ	I-NP
O	544	549	mouse	mouse	NN	I-NP
B-Cell	550	558	cerebral	cerebral	JJ	I-NP
I-Cell	559	570	endothelial	endothelial	JJ	I-NP
I-Cell	571	576	cells	cell	NNS	I-NP
O	577	579	to	to	TO	B-PP
O	580	583	the	the	DT	B-NP
O	584	588	CD47	CD47	NN	I-NP
O	589	595	ligand	ligand	NN	I-NP
O	596	610	thrombospondin	thrombospondin	NN	I-NP
O	611	612	1	1	CD	I-NP
O	613	614	(	(	(	O
O	614	617	TSP	TSP	NN	B-NP
O	617	618	-	-	HYPH	B-NP
O	618	619	1	1	CD	I-NP
O	619	620	)	)	)	O
O	621	628	induced	induce	VBD	B-VP
O	629	631	an	an	DT	B-NP
O	632	642	increasing	increase	VBG	I-NP
O	643	649	amount	amount	NN	I-NP
O	650	652	of	of	IN	B-PP
B-Cell	653	657	cell	cell	NN	B-NP
O	658	663	death	death	NN	I-NP
O	663	664	,	,	,	O
O	665	672	whereas	whereas	IN	O
O	673	685	cytotoxicity	cytotoxicity	NN	B-NP
O	686	689	was	be	VBD	B-VP
O	690	703	significantly	significantly	RB	I-VP
O	704	713	decreased	decrease	VBN	I-VP
O	714	716	in	in	IN	B-PP
B-Cell	717	725	cerebral	cerebral	JJ	B-NP
I-Cell	726	737	endothelial	endothelial	JJ	I-NP
I-Cell	738	743	cells	cell	NNS	I-NP
O	744	751	derived	derive	VBN	B-VP
O	752	756	from	from	IN	B-PP
O	757	761	CD47	CD47	NN	B-NP
O	762	770	knockout	knockout	NN	I-NP
O	771	775	mice	mouse	NNS	I-NP
O	775	776	.	.	.	O

O	777	780	The	The	DT	B-NP
O	781	789	specific	specific	JJ	I-NP
O	790	794	CD47	CD47	NN	I-NP
O	794	795	-	-	HYPH	O
O	795	805	activating	activate	VBG	B-VP
O	806	813	peptide	peptide	NN	B-NP
O	813	814	,	,	,	O
O	815	819	4N1K	4N1K	NN	B-NP
O	819	820	,	,	,	O
O	821	830	similarly	similarly	RB	B-ADVP
O	831	838	induced	induce	VBD	B-VP
B-Cell	839	843	cell	cell	NN	B-NP
O	844	849	death	death	NN	I-NP
O	850	852	in	in	IN	B-PP
O	853	858	human	human	JJ	B-NP
B-Cell	859	864	brain	brain	NN	I-NP
I-Cell	865	878	microvascular	microvascular	JJ	I-NP
I-Cell	879	890	endothelial	endothelial	JJ	I-NP
I-Cell	891	896	cells	cell	NNS	I-NP
O	896	897	.	.	.	O

O	898	907	Promotion	Promotion	NN	B-NP
O	908	910	of	of	IN	B-PP
O	911	923	inflammation	inflammation	NN	B-NP
O	924	927	was	be	VBD	B-VP
O	928	932	also	also	RB	I-VP
O	933	941	involved	involve	VBN	I-VP
O	942	949	because	because	IN	B-SBAR
O	950	955	lower	low	JJR	B-NP
O	956	959	TSP	TSP	NN	I-NP
O	959	960	-	-	HYPH	B-NP
O	960	961	1	1	CD	I-NP
O	962	965	was	be	VBD	B-VP
O	966	970	able	able	JJ	B-ADJP
O	971	973	to	to	TO	B-VP
O	974	976	up	up	RB	I-VP
O	976	977	-	-	HYPH	I-VP
O	977	985	regulate	regulate	VB	I-VP
O	986	989	the	the	DT	B-NP
O	990	998	adhesion	adhesion	NN	I-NP
O	999	1008	molecules	molecule	NNS	I-NP
O	1009	1022	intercellular	intercellular	JJ	B-NP
O	1023	1031	adhesion	adhesion	NN	I-NP
O	1032	1040	molecule	molecule	NN	I-NP
O	1040	1041	-	-	HYPH	B-NP
O	1041	1042	1	1	CD	I-NP
O	1043	1046	and	and	CC	O
O	1047	1055	vascular	vascular	JJ	B-NP
O	1056	1060	cell	cell	NN	I-NP
O	1061	1069	adhesion	adhesion	NN	I-NP
O	1070	1078	molecule	molecule	NN	I-NP
O	1078	1079	-	-	HYPH	B-NP
O	1079	1080	1	1	CD	I-NP
O	1080	1081	.	.	.	O

O	1082	1089	Finally	Finally	RB	B-ADVP
O	1089	1090	,	,	,	O
O	1091	1095	CD47	CD47	NN	B-NP
O	1096	1105	signaling	signaling	NN	I-NP
O	1106	1109	may	may	MD	B-VP
O	1110	1118	suppress	suppress	VB	I-VP
O	1119	1131	angiogenesis	angiogenesis	NN	B-NP
O	1132	1139	because	because	IN	B-SBAR
O	1140	1144	4N1K	4N1K	NN	B-NP
O	1145	1158	significantly	significantly	RB	B-ADVP
O	1159	1168	inhibited	inhibit	VBD	B-VP
B-Cell	1169	1180	endothelial	endothelial	JJ	B-NP
I-Cell	1181	1185	cell	cell	NN	I-NP
O	1186	1195	migration	migration	NN	I-NP
O	1196	1199	and	and	CC	O
B-Tissue	1200	1204	tube	tube	NN	B-NP
O	1205	1214	formation	formation	NN	I-NP
O	1215	1217	in	in	FW	B-ADVP
O	1218	1223	vitro	vitro	FW	I-ADVP
O	1223	1224	.	.	.	O

O	1225	1227	We	We	PRP	B-NP
O	1228	1236	conclude	conclude	VBP	B-VP
O	1237	1241	that	that	IN	B-SBAR
O	1242	1246	CD47	CD47	NN	B-NP
O	1247	1256	signaling	signaling	NN	I-NP
O	1257	1260	can	can	MD	B-VP
O	1261	1271	negatively	negatively	RB	I-VP
O	1272	1278	affect	affect	VB	I-VP
O	1279	1282	the	the	DT	B-NP
O	1283	1292	viability	viability	NN	I-NP
O	1293	1296	and	and	CC	I-NP
O	1297	1305	function	function	NN	I-NP
O	1306	1308	of	of	IN	B-PP
B-Cell	1309	1317	cerebral	cerebral	JJ	B-NP
I-Cell	1318	1329	endothelial	endothelial	JJ	I-NP
I-Cell	1330	1335	cells	cell	NNS	I-NP
O	1335	1336	,	,	,	O
O	1337	1344	further	further	RB	B-VP
O	1345	1355	supporting	support	VBG	I-VP
O	1356	1359	the	the	DT	B-NP
O	1360	1366	notion	notion	NN	I-NP
O	1367	1371	that	that	IN	B-SBAR
O	1372	1376	CD47	CD47	NN	B-NP
O	1377	1380	may	may	MD	B-VP
O	1381	1383	be	be	VB	I-VP
O	1384	1385	a	a	DT	B-NP
O	1386	1395	potential	potential	JJ	I-NP
B-Multi-tissue_structure	1396	1409	neurovascular	neurovascular	JJ	I-NP
O	1410	1416	target	target	NN	I-NP
O	1417	1420	for	for	IN	B-PP
O	1421	1427	stroke	stroke	NN	B-NP
O	1428	1431	and	and	CC	I-NP
B-Organ	1432	1437	brain	brain	NN	I-NP
O	1438	1444	injury	injury	NN	I-NP
O	1444	1445	.	.	.	O

